Stay updated with breaking news from Seikagaku corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The interstitial cystitis drugs market is expected to grow by USD 283.95 mn from 2021 to 2025, progressing at a CAGR of 5.06%, according to. ....
Global Viscosupplementation System Market Report 2021: Growing Demand for Minimally Invasive Procedures prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Viscosupplementation System Market Report 2021: Growing Demand for Minimally Invasive Procedures prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS™ (PTP-001) for the . Bioventus, Inc.March 11, 2021 GMT DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported that the first patients have been enrolled and dosed in its Phase 1 open-label, dose-escalation study of MOTYS (PTP-001) with Dr. Shailesh Patel, M.D. at Coastal Carolina Research Center, South Carolina. MOTYS is a placental tissue particulate comprised of amnion, chorion and umbilical cord tissue from full-term, healthy births and is provided sterile in micronized form. ....